$5.98 -0.16 (-2.61%) Merrimack Pharmaceuticals Inc - NASDAQ

Sep. 23, 2016 | 04:00 PM
Last Trade: 5.98
Trade Time: Sep 23 04:00 PM Eastern Daylight Time
Change: -0.16 (-2.61%)
Prev Close: 6.14
Open: 6.13
Bid: 5.98
Ask: 5.99
  1. Merrimack Amends MM-121 Phase 2 Clinical Study in Heregulin-Positive Non-Small Cell Lung Cancer to Support Potential Registration

    Benzinga | Dec. 22, 2015 | 16:17PM EST
  2. Merrimack and Baxalta Announce Publication of the ONIVYDEâ„¢ (irinotecan liposome injection) NAPOLI-1 Study in The Lancet

    Benzinga | Nov. 23, 2015 | 08:03AM EST
  3. PharmaEngine Announces FDA Approves Merrimack's ONIVYDE

    Benzinga | Oct. 23, 2015 | 04:22AM EST
  4. Merrimack Comfirms U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer

    Benzinga | Oct. 22, 2015 | 13:12PM EST
  5. U.S. FDA Grants Priority Review for MM-398 New Drug Application

    Benzinga | Jun. 25, 2015 | 07:05AM EST
  6. Benzinga's Top Initiations

    Benzinga | May. 13, 2015 | 09:17AM EST
  7. First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients

    Benzinga | Apr. 21, 2015 | 08:03AM EST
  8. Merrimack Pharma Reports Final Clinical Results for MM-302 Phase 1 Study

    Benzinga | Apr. 20, 2015 | 16:01PM EST
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  10. Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, ...

    GuruFocus | Dec. 14, 2014 | 21:57PM EST
  11. Top 5 Biotech Stocks Over The Past Year

    Benzinga | Oct. 6, 2014 | 14:28PM EST
  12. Merrimack Pharmaceuticals

    IBD | Sep. 30, 2014 | 18:37PM EST
  13. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 17:03PM EST
  14. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  15. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
Trading Center